German Christopher Paul bought RYTM
May 15, 2026 · Form 4 insider transaction
German Christopher Paul bought 1,687 shares of Rhythm Pharmaceuticals, Inc. at $56.69 per share, a transaction worth $95.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,687
Price
$56.69
Total value
$95.6K
InsiderGerman Christopher Paul
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 15, 2026
Filing dateMay 19, 2026
Shares owned after1,888
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes an aggregate of 201 shares of Common Stock purchased pursuant to the Rhythm Pharmaceuticals, Inc. Employee Stock Purchase Plan.